Valneva SE Sponsored ADR (VALN) shares ended the last trading session 17.4% higher at $7.32. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

French drugmaker Valneva said on Wednesday it will conduct a trial about the use of its COVID-19 vaccine candidate VLA2001 as a booster jab following a mRNA vaccination or natural infection.

SEATTLE & HEIDELBERG, Germany--(BUSINESS WIRE)--AGC Biologics, your friendly CDMO expert, today announced a development and manufacturing services agreement with specialty vaccine company Valneva SE ...

French biotech firm Valneva said on Thursday its COVID-19 vaccine candidate was efficient as a booster for people who had received the same shot as an initial vaccination.

Valneva obtains exclusive worldwide license for LimmaTech’s S4V Shigella vaccine candidate and adds an attractive Phase 2 clinical asset to Valneva’s R&D pipeline LimmaTech to receive upfront ...

Valneva will provide a live webcast of its first quarter 2025 results conference call beginning at 3 p.m. CEST/9 a.m. EDT today. This webcast will also be available on the Company’s website.

Valneva’s COVID-19 vaccine, VLA2001, is the only inactivated whole-virus COVID-19 vaccine approved in Europe 36 and was the first COVID-19 vaccine to receive a full marketing authorization from ...

Valneva currently carries a Zacks Rank #3 (Hold). A better-ranked stock in the overall healthcare sector is Arbutus Biopharma ABUS, carrying a Zacks Rank #2 (Buy) at present.

Valneva SE: Underfollowed French Biotech, 2 Interesting Vaccine Approvals Expected By 23-25 Feb. 26, 2023 3:03 AM ET Valneva SE (VALN) Stock PFE, XLV, IBB XBI VALN 8 Comments ...

5 Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ® - Valneva 6 Vaccines on the table as chikungunya outbreak intensifies in India - BlueDot ...

Valneva SE fell as much as 15% after the European Union slashed its order of the French company’s Covid-19 vaccine. European countries will now buy 1.25 million doses of Valneva’s vaccine ...

Shares of Valneva VALN have dropped 61.5% in the trailing 12 months compared with the industry’s 39.6% decline. This substantial decline was attributable to the revision for the supply of doses ...